Interferon-α-inducible protein 6 (IFI6) has been extensively studied across various cancer types, such as lung adenocarcinoma, myeloma, gastric cancer, pancreatic cancer, breast cancer, prostate cancer, and ovarian cancer [13,14,15,16,17,18,19,20]. Here, IFI6 is linked to breast carcinoma.